• Anne-Sophie Wattiez, Olivia J Gaul, Adisa Kuburas, Erik Zorrilla, Jayme S Waite, Bianca N Mason, William C Castonguay, Mengya Wang, Bennett R Robertson, and Andrew F Russo.
• Department of Molecular Physiology and Biophysics, University of Iowa, 51 Newton Rd, Iowa City, IA, 52242, USA. anne-sophie-wattiez@uiowa.edu.
• J Headache Pain. 2021 Jun 30; 22 (1): 62.

BackgroundCircadian patterns of migraine attacks have been reported by patients but remain understudied. In animal models, circadian phases are generally not taken into consideration. In particular, rodents are nocturnal animals, yet they are most often tested during their inactive phase during the day. This study aims to test the validity of CGRP-induced behavioral changes in mice by comparing responses during the active and inactive phases.MethodsMale and female mice of the outbred CD1 strain were administered vehicle (PBS) or CGRP (0.1 mg/kg, i.p.) to induce migraine-like symptoms. Animals were tested for activity (homecage movement and voluntary wheel running), light aversive behavior, and spontaneous pain at different times of the day and night.ResultsPeripheral administration of CGRP decreased the activity of mice during the first hour after administration, induced light aversive behavior, and spontaneous pain during that same period of time. Both phenotypes were observed no matter what time of the day or night they were assessed.ConclusionsA decrease in wheel activity is an additional clinically relevant phenotype observed in this model, which is reminiscent of the reduction in normal physical activity observed in migraine patients. The ability of peripheral CGRP to induce migraine-like symptoms in mice is independent of the phase of the circadian cycle. Therefore, preclinical assessment of migraine-like phenotypes can likely be done during the more convenient inactive phase of mice.

17 keywords...

hide…